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ABSTRACT 
Here is reported an unusual case of substance dependence with buprenorphine, 
mephentermine, & promethazine. This combination taken through intramuscular route produced a 
relatively mild & delayed abstinence syndrome with features viz. increased sleep and appetite in the 
patients. The neurophysiological basis for use of this rare form of additive (mephentermine) with 
buprenorphine is speculated. 
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Opium (afeem) (Aggarwal,1995) a 
derivative of "Papaver somniferum" and its 
congeners like heroine, morphine, methadone 
and buprenorphine are well recognised as drugs 
for abuse and dependence. According to one 
estimate 0.2-0.6% of Indian urban population 
need treatment for opioid dependent use 
(Malhotraetal.,1997). 
Buprenorphine, a semi synthetic opioid 
and partial Mu (u) agonist has potential analgesic 
properties and a moderate abuse potential. It 
has a mild and prolonged withdrawal syndrome 
(Aggarwal.1995). It is abused parenterally mainly 
by ex-heroin addicts (Malhotra et al.,1997). 
It has been used for de-addiction of uses 
of heroin, cocaine or both via parentaral route 
(Jaffe,1995). Here we report a rare case of 
substance dependence with buprenorphine, 
mephentermine and promethazine. 
CASE REPORT 
Mr. K.K. was admitted to special ward in 
G.B. Pant Hospital in April.1998 with following 
complaints. Since four years he had been 
injecting 2 ml (0.6mg) buprenorphine, 2 ml 
(30mg) of mephentermine and 2 ml (50mg) of 
promethazine. Initially he had started with 1 ml 
(0.3 mg) injection of buprenorphine in OD or BD 
dose which had supposedly been prescribed by 
a local physician as a safer alternative to cap. 
proxyvon (dextropropoxyphane 65 mg+ 
acetaminophen 100 mg) to which he had been 
addicted earlier. He later increased the frequency 
of injection to about 5-6 per day (1.5-1.8 mg of 
buprenorphine). Later, the patient developed 
complaints of giddiness which was diagnosed 
as hypotension (low B.P.) by a local practioner 
who gave him one injection of mephentermine 
(1 ml). After this the patient"started adding 1 ml 
(15 mg) of mephentermine (o each ml (0.3mg) 
of buprenorphine. 
In the past 2 months before admission, 
patient started adding 4 ml (100 mg) 
promethazine to 1 ml of buprenorphine and 1 
ml of mephentermine to make up a single dose. 
He took his last dose consisting of 2 ml (0.6 mg) 
of buprenorphine, 2 ml (30 mg) of 
mephentermine & 2 ml (50 mg) of promethazine 
on the previous day of his admission to the 
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hospital at about 14:30 hrs. 
Past History (Family & Personal)-Patient 
had been abusing opium (about 10 mg/day), 
alcohol (1-2 pegs/day) since 22 years of age. 
He met with an accident in 1987 and during 
subsequent hospitalisation his family members 
came to know of his drug habits. To leave this 
habit he started taking cap. proxyvon 1-2/day. 
He stopped taking alcohol and opium and 
increased to 5-6 cap. of same drug per day and 
got addicted. He turned to buprenorphine to 
leave proxyvon and got hooked. 
Patient belonged to an affluent and 
educated family. He was a graduate and had 
worked for some time in the family transport 
business. After becoming addicted to drugs he 
stopped working. He used to borrow large sum 
from his friends and relatives. Later he started 
pawning the household valuables to get money. 
His family members disowned him when they 
came to know his drug habit. His wife, fed up of 
his manipulative and irresponsible behviour, left 
him and finally divorced him. 
Management & Course in the ward- After 
a detailed work up, patient was searched 
thoroughly for possession of any further doses 
and was placed under strict supervision. 
All baseline investigations were normal. 
Treatment was started with tab clonidine 0.15 
mg, tab. tramadol hydrochloride 50 mg & tab. 
chlordiazepoxide 50 mg. Tablet clonidine had to 
be withdrawn on 2
n
d day due to persistent fall in 
BP. 
Withdrawal symptoms were studied using 
the substance withdrawal rating proforma 
(Bradley et al.,1987). Typical withdrawal 
symptoms like mydriasis, anxiety, restlessness, 
low BP were felt from 4
t
h day of complete 
abstinence & became maximum on 6
t
h day. On 
this day, patient had some "craving' forthisdose, 
felt very weak and feverish. He also had 
mydriasis, tremors, anxiety, restlessness & 
irritability. Curiously, patient's appetite and sleep 
increased instead of decreasing. Also, yawning, 
lacrimation, rhinorrhoea, non-specific aches & 
pains, numbing of hand & feet and feeling of 
being cold were noted by the patient. On the 8* 
day of admission patient left the hospital and 
took another dose. Subsequently, he was 
discharged on day 9 on same treatment. 
DISCUSSION 
Opioids, amphetamines and cocaine have 
common mechanisms of action on dopaminergic 
pathway which may account for their synergistic 
effects. Euphoria & analgesia are produced due 
to release of dopamine or block of its reuptake 
by these substances (Jaffe et al., 1997). 
Mephentermine after demethylation is 
converted to amphetamine, which has 
euphoriant and brain stimulant effect, is a potent 
drug of for abuse. Its methylation reduces its 
properties for release and up take of 
norepinephrine which is responsible for most its 
actions (King & Ellinwood,1997). So, 
mephantermine may share some of properties 
of amphetamine. It may act as brain stimulant 
and add to effect of buprenorphine in this case. 
Mephentermine, an alpha adrenergic 
agonist, has action similarto Ephsdrine. Its onset 
of action is prompt (between 10 to 15 minutes) 
and its effect lasts for many hours. It is given in 
form of IM, IV injection or infusion in drip with 
titration of dose according to B.P. response 
(Goodman & Gillman, 1991). It could beeffective 
in countering the fall in B.P. reported after IV 
buprenorphine when mixed in same syringe. 
Conclusively, to the authors' knowledge 
there are no reported case of use of 
mephentermine as agent of abuse or as an 
additive to other drugs like buprenorphine. This 
report highlights the use of a rare and interesting 
combination of buprenorphine, mephentermine 
and promethazine for parenteral abuse. 
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